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Congenital diaphragmatic hernia (CDH), a life-
threatening anomaly, attracts much attention 
amongst physicians, researchers and embryologists 
since its initial reported in 1679 by Riverius.1 Most 
CDH occurrs through either the right or left poste-
rolateral defect of the diaphragm. Left side CDH 
is more common than a right CDH. Approximately 
half of infants with CDH are associated with other 
organ anomalies.
1.  Evolution of Etiologic Research
As CDH always combines with lung hypoplasia, re-
search on the etiology of CDH usually focuses on 
the development of the lungs. Although the exact 
mechanism of diaphragm development is still un-
clear, many pathways and genes have been found to 
regulate pulmonary development. However, contro-
versies also exist around the consequence of de-
fective lungs or the defective diaphragm, and which 
organ influences the other. The dual-hit hypothesis 
was postulated by Keijzer et al.2
The retinoid acid signaling pathway is hypo-
thesized to play an important role in both the oc-
currence of CDH and lung hypoplasia. Retinol is 
con verted to retinal by alcoholdehydrogenase, and 
the retinal is further converted to retinoid acid (RA) 
by retinaldehydrogenase.3 Exposure to teratogens 
such as nitrofen, bisdiamine will cause diaphragmatic 
defect by inhibiting retinaldehydrogenase.4 Retin-
oid acid will bind to RA heterodimeric receptors 
(RAR-RXR) to form the RA-RAR-RXR complex, which 
will further influence the other factors associated 
with lung development such as fibroblast growth 
factor (FGF), sonic Hedgehog (SHH), bone morpho-
genetic protein 4 (BMP4).
Chicken Ovalbumin Upstream Promotor-Trans-
cription Factor II (COUP-TF II) will down-regulate 
the expression of RA-RAR-RXR complex. The COUP- 
TF II and GATA-binding protein 4 (GATA4) also in-
teract with FOG2 to interfere the muscular layer 
development of the diaphragm.3 Thus, the most 
important candidate region related to the devel-
opment of CDH so far was found on chromosome 
15q26. Several genes in this area have been found 
to correlate with the development of CDH. Among 
them, the coup-tf II was the one most likely to be 
associated with this process.5 Other candidate fac-
tors mentioned above, including fog2 (8q23),6 
GATA4,7 FGF,8 stimulated by retinoic acid 6 (stra6, 
15q24.1),9 BMP4 and SHH were also reported to be 
related with the development of CDH.
2.  Evolution of the Predictors of 
Outcome
The survival of infants with CDH is obviously re-
lated to the residual lung function. It is reasonable 
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to predict the survival or mortality by lung volume. 
Many clinical investigators predicted the outcome 
of CDH with parameters related to lung function, 
such as Bohn’s ventilation index,10 modified venti-
lation index,11 and oxygen index.
As a result of the advances in technology, the 
assessment of fetal lung volume (FLV) has become 
possible. The roles of the imaging examination of 
CDH in infants are to clarify the defect and associ-
ated anomalies, and to define the degree of pul-
monary hypoplasia, both of which are closely related 
to survival outcome. Methods exist for evaluating 
the lung volume in CDH fetuses, either with fetal 
MRI12 or 3D echography,13 both of which have prom-
ising results. Either absolute or relative FLV were 
associated with the survival or use of extracorpor-
eal membrane oxygenation.14,15 Bonfils et al16 had 
found the best FLV cut-off ratio for predict mortal-
ity, which was 30% of expected FLV. FLV measure-
ment has high reliability and validity with good 
inter-observer agreement.17 As suggested by Busing 
et al18 however, the FLV is better performed after 
30 weeks of gestational age for its higher prognostic 
power. The use of other parameters such as lung-
to-head ratio19 and FLV/body weight ratio20 were 
also reported.
3.  Evolution of Management
With a greater understanding the pathophysiology 
of CDH and lung protection strategy, it is clear that 
deferring surgery and using gentle ventilation are 
considered the optimal management by most clini-
cians. Permissive hypercapnea with gentle venti-
lation21 can decrease morbidity, such as air-leak 
sequence, especially of the contralateral pneumot-
horax which, if happened, will further compromise 
the residual lung function.22 The concept of no pro-
phylactic chest tube placement after surgery was 
also accepted by more and more physicians. Ad-
vances of other technologies, such as high frequency 
oscillatory ventilation23 and inhaled NO24 have thus 
far, shown no such promising results.
4.  Evolution of Surgical Repair
Traditionally, surgical repair of CDH is done through 
subcostal laparotomy for left side CDH, and through 
thoracotomy for right side CDH. A tension-free re-
pair of the defective diaphragm is key to reducing 
the recurrence rate. When the diaphragmatic de-
fect is small, it can be repaired directly. However, 
when the defect is large, a prosthetic patch or 
autologus muscle flap can be used to achieve a 
tension-free repair.25 Recently, a minimal invasive 
approach has gained attraction. Either laparoscopic 
or thoracoscopic approach is feasible for CDH re-
pair, although thoracoscopy seems to be prefera-
ble for its ease of performance.26 In a series of 
29 thoracoscopic repairs of CDH, Cho et al26 re-
ported that the overall complications were similar 
between the groups of open and thoracoscopy ap-
proaches. However, thoracoscopic repair seemed 
to carry a higher recurrence rate as compared to 
the open repair, although the difference was not 
statistically significant (20.7% vs. 6.9%, p = 0.25).26 
To prevent aggravation of pulmonary hypertension 
during patient transfer, it is now our policy to op-
erate the patient in the neonate ICU. Furthermore, 
after the surgical repair of diaphragm, chest tube 
is not inserted to prevent rapid lung expansion 
with resulting pneumothorax.21
5.  Evolution of Survival
The survival rate has increased in recent decades, 
particularly in developing countries. The survival 
rate of infants with CDH in India27 and Malaysia28 
were reported to be approximately 50%. In Israel, 
the survival rate was reported to have increased 
from 61.3% in 1985−1995 to 86.5% in 1996−2007.29 
In Korea, the survival rate was reported to have 
increased from 53% in 1990−1998 to 77% in 1998−
2005.30 In Taiwan, Chao et al31 found that their 
survival rate has improved to 79%, superior to pre-
vious local data. Although the comparison was not 
performed in the same institutions, it still signaled 
the improvement of survival.
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